Literature DB >> 8581002

The insulin-like growth factor system in the prostate.

D M Peehl1, P Cohen, R G Rosenfeld.   

Abstract

The insulin-like growth factor (IGF) system is involved in the regulation of cell growth. The system involves a network of molecules that includes the IGFs themselves (IGF-I and -II), IGF receptors (types I and II), IGF-binding proteins (IGFBP-1 through -6), and IGFBP proteases. Characterization of this complex system in the prostate has recently been initiated. Prostatic cell lines as well as primary cultures of prostatic epithelial and stromal cells have been analyzed for expression of IGFs, receptors, and IGFBPs. Prostatic epithelial cells and, quite likely, stromal cells as well respond to the mitogenic activity of IGFs via the type I IGF receptor. Prostatic stromal cells synthesize and secrete IGF-II; there is evidence that prostatic cell lines also synthesize IGFs, but this has not been confirmed in primary cultures of prostatic epithelial cells. Prostatic stromal and epithelial cells secrete a number of IGFBPs. The biological impact of some of these IGFBPs on the growth of prostatic cells has been examined, and proteolytic cleavage of IGFBP-3 by prostate-specific antigen (PSA) has been demonstrated. Aberrations in several elements of the IGF system have been observed in stromal cells derived from benign prostatic hyperplasia (BPH). The IGF system may therefore have a part in the etiology of BPH as well as in normal and malignant processes in the prostate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581002     DOI: 10.1007/bf00185974

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  37 in total

Review 1.  Histochemistry of the prostate.

Authors:  W C Allsbrook; W W Simms
Journal:  Hum Pathol       Date:  1992-03       Impact factor: 3.466

Review 2.  Clinical aspects of insulin-like growth factor binding proteins.

Authors:  P Cohen; P J Fielder; Y Hasegawa; H Frisch; L C Giudice; R G Rosenfeld
Journal:  Acta Endocrinol (Copenh)       Date:  1991

Review 3.  The insulin-like growth factors.

Authors:  W S Cohick; D R Clemmons
Journal:  Annu Rev Physiol       Date:  1993       Impact factor: 19.318

4.  Ductal budding and branching patterns in the developing prostate.

Authors:  B G Timms; T J Mohs; L J Didio
Journal:  J Urol       Date:  1994-05       Impact factor: 7.450

5.  Insulin-like growth factor-I receptors in human hyperplastic prostate tissue: characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analog.

Authors:  G Fiorelli; A De Bellis; A Longo; S Giannini; A Natali; A Costantini; G B Vannelli; M Serio
Journal:  J Clin Endocrinol Metab       Date:  1991-04       Impact factor: 5.958

6.  Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells.

Authors:  Y Oh; H L Müller; H Pham; R G Rosenfeld
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

7.  Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour.

Authors:  O Ogawa; M R Eccles; J Szeto; L A McNoe; K Yun; M A Maw; P J Smith; A E Reeve
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

Review 8.  Structure, evolution, expression and regulation of insulin-like growth factors I and II.

Authors:  P Rotwein
Journal:  Growth Factors       Date:  1991       Impact factor: 2.511

Review 9.  Etiology and disease process of benign prostatic hyperplasia.

Authors:  J T Isaacs; D S Coffey
Journal:  Prostate Suppl       Date:  1989

10.  Insulin-like growth factor-binding protein-3 expression and secretion by cultures of human prostate epithelial cells and stromal fibroblasts.

Authors:  R S Birnbaum; J L Ware; S R Plymate
Journal:  J Endocrinol       Date:  1994-06       Impact factor: 4.286

View more
  13 in total

1.  Characteristics of a human prostate stromal cell line related to its use in a stromal-epithelial coculture model for the study of cancer chemoprevention.

Authors:  Lena Diaw; Mark Roth; Debra A Schwinn; Mary E d'Alelio; Lisa J Green; Joseph A Tangrea
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 May-Jun       Impact factor: 2.416

Review 2.  A review of the anticancer potential of the antimalarial herbal cryptolepis sanguinolenta and its major alkaloid cryptolepine.

Authors:  C Ansah; K B Mensah
Journal:  Ghana Med J       Date:  2013-09

3.  Prostate cancer: risk assessment and diagnostic approaches.

Authors:  L G Gomella; F Labrie; E J Gamito; M K Brawer
Journal:  Rev Urol       Date:  2001

4.  Bladder outlet obstruction: etiology and evaluation.

Authors:  Roger R Dmochowski
Journal:  Rev Urol       Date:  2005

Review 5.  Molecular pathology of prostate cancer.

Authors:  C Hughes; A Murphy; C Martin; O Sheils; J O'Leary
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

6.  Osteoblasts induce prostate cancer proliferation and PSA expression through interleukin-6-mediated activation of the androgen receptor.

Authors:  Yi Lu; Jian Zhang; Jinlu Dai; Lindsay A Dehne; Atsushi Mizokami; Zhi Yao; Evan T Keller
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

7.  Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor.

Authors:  A Chott; Z Sun; D Morganstern; J Pan; T Li; M Susani; I Mosberger; M P Upton; G J Bubley; S P Balk
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

Review 8.  An introduction to acinar pressures in BPH and prostate cancer.

Authors:  Panikar Wadhera
Journal:  Nat Rev Urol       Date:  2013-05-14       Impact factor: 14.432

9.  Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels.

Authors:  Won Tae Kim; Seok Joong Yun; Young Deuk Choi; Gi-Young Kim; Sung-Kwon Moon; Yung Hyun Choi; Isaac Yi Kim; Wun-Jae Kim
Journal:  J Korean Med Sci       Date:  2011-09-01       Impact factor: 2.153

10.  The impact of diabetes type 2 in the pathogenesis of benign prostatic hyperplasia: a review.

Authors:  K Stamatiou; M Lardas; E Kostakos; V Koutsonasios; E Michail
Journal:  Adv Urol       Date:  2009-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.